C87436 Activators encompass a diverse array of chemical compounds that indirectly influence the functional activity of C87436 through specific intracellular signaling pathways. Forskolin, by raising intracellular cAMP levels, indirectly heightens the activity of C87436 by activating PKA which phosphorylates substrates within the same signaling cascade as C87436. Similarly, PMA, a DAG analog, activates PKC, which is known to phosphorylate proteins that interact with or regulate C87436, leading to an enhancement of its functionality. Ionomycin and A23187, both calcium ionophores, increase the intracellular calcium concentration, subsequently activating calcium-dependent pathways that C87436 is a part of and thus indirectly enhancing its activity. Compounds like Epigallocatechin gallate and Zaprinast, through kinase inhibition and elevation of cGMP levels respectively, lead to the activation of pathways or removal of inhibitory phosphorylations that can result in the elevated activity of C87436.
Moreover, the inhibition of signal transduction components by LY294002 (PI3K inhibitor), SB203580 (p38 MAPK inhibitor), U0126 (MEK1/2 inhibitor), and Isoquinoline sulfonamide (PKA inhibitor) can cause a shift in cellular signaling dynamicsfavorable to the pathways involving C87436, thereby indirectly augmenting its activity. Through the inhibition of PI3K, LY294002 can modulate the activity of downstream molecules like Akt, which may intersect with the pathways C87436 is involved in, leading to its enhanced function. SB203580 and U0126, by inhibiting p38 MAPK and MEK1/2 respectively, change the balance of cellular signaling to promote the activation of C87436. Additionally, Sildenafil and Zaprinast, both PDE5 inhibitors, increase cGMP levels, which activate PKG and can phosphorylate substrates in signaling cascades that include C87436, potentially enhancing its activity. Bisindolylmaleimide I, although a PKC inhibitor, can refine signaling by selectively inhibiting specific PKC isoforms, resulting in a net increase in C87436 activity by modifying the protein's signaling environment.
SEE ALSO...
Items 11 to 11 of 11 total
Display:
Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
---|---|---|---|---|---|---|
Bisindolylmaleimide I (GF 109203X) | 133052-90-1 | sc-24003A sc-24003 | 1 mg 5 mg | $103.00 $237.00 | 36 | |
Bisindolylmaleimide I is a specific PKC inhibitor. By selectively inhibiting certain PKC isoforms, it may alter signaling pathways in a way that indirectly enhances the activity of C87436. |